SNN vs. GEHC, PHG, ZBH, SOLV, PEN, GKOS, BLCO, INSP, NARI, and PRCT
Should you be buying Smith & Nephew stock or one of its competitors? The main competitors of Smith & Nephew include GE HealthCare Technologies (GEHC), Koninklijke Philips (PHG), Zimmer Biomet (ZBH), Solventum (SOLV), Penumbra (PEN), Glaukos (GKOS), Bausch + Lomb (BLCO), Inspire Medical Systems (INSP), Inari Medical (NARI), and PROCEPT BioRobotics (PRCT). These companies are all part of the "medical equipment" industry.
Smith & Nephew vs.
Smith & Nephew (NYSE:SNN) and GE HealthCare Technologies (NASDAQ:GEHC) are both large-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, earnings, institutional ownership, community ranking, media sentiment, valuation and risk.
Smith & Nephew received 426 more outperform votes than GE HealthCare Technologies when rated by MarketBeat users. However, 57.89% of users gave GE HealthCare Technologies an outperform vote while only 54.43% of users gave Smith & Nephew an outperform vote.
Smith & Nephew pays an annual dividend of $0.55 per share and has a dividend yield of 2.2%. GE HealthCare Technologies pays an annual dividend of $0.14 per share and has a dividend yield of 0.2%. GE HealthCare Technologies pays out 3.8% of its earnings in the form of a dividend.
Smith & Nephew has a beta of 0.84, suggesting that its stock price is 16% less volatile than the S&P 500. Comparatively, GE HealthCare Technologies has a beta of 1.11, suggesting that its stock price is 11% more volatile than the S&P 500.
GE HealthCare Technologies has a consensus price target of $96.00, suggesting a potential upside of 7.70%. Given GE HealthCare Technologies' stronger consensus rating and higher probable upside, analysts plainly believe GE HealthCare Technologies is more favorable than Smith & Nephew.
GE HealthCare Technologies has a net margin of 8.56% compared to Smith & Nephew's net margin of 0.00%. GE HealthCare Technologies' return on equity of 25.19% beat Smith & Nephew's return on equity.
25.6% of Smith & Nephew shares are owned by institutional investors. Comparatively, 82.1% of GE HealthCare Technologies shares are owned by institutional investors. 1.0% of Smith & Nephew shares are owned by company insiders. Comparatively, 0.3% of GE HealthCare Technologies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
GE HealthCare Technologies has higher revenue and earnings than Smith & Nephew.
In the previous week, GE HealthCare Technologies had 7 more articles in the media than Smith & Nephew. MarketBeat recorded 8 mentions for GE HealthCare Technologies and 1 mentions for Smith & Nephew. Smith & Nephew's average media sentiment score of 1.34 beat GE HealthCare Technologies' score of 0.86 indicating that Smith & Nephew is being referred to more favorably in the media.
Summary
GE HealthCare Technologies beats Smith & Nephew on 14 of the 19 factors compared between the two stocks.
Get Smith & Nephew News Delivered to You Automatically
Sign up to receive the latest news and ratings for SNN and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Smith & Nephew Competitors List
Related Companies and Tools
This page (NYSE:SNN) was last updated on 1/27/2025 by MarketBeat.com Staff
